Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin-Reference-Cited by-同舟云学术

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

Published:2010-03-26 Issue:2 Volume:52 Page:421-429
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Akuta Norio,Suzuki Fumitaka,Hirakawa Miharu,Kawamura Yusuke,Yatsuji Hiromi,Sezaki Hitomi,Suzuki Yoshiyuki,Hosaka Tetsuya,Kobayashi Masahiro,Kobayashi Mariko,Saitoh Satoshi,Arase Yasuji,Ikeda Kenji,Chayama Kazuaki,Nakamura Yusuke,Kumada Hiromitsu

Publisher

Wiley

Subject

Hepatology

Reference39 articles.

1. Progress of chronic hepatitis C: results of a large, prospective cohort study;Niederau;Hepatology,1998

2. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group;Kenny-Walsh;N Engl J Med,1999

3. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load;Tsubota;J Med Virol,2005

4. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

5. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients;Medicine;2023-07-14

2. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia;Archives of Biological Sciences;2023

3. ASSESSING PREDICTORS OF DIRECTLY ACTING ANTIVIRALS’ FAILURE AS A FURTHER STEP TOWARDS MORE EFFICIENT HCV ELIMINATION PROGRAMS: IL28B (IFNL4) GENE POLYMORPHISM HAS NO ROLE WHILE HIGHER ESTIMATED CREATININE CLEARANCE IS A FORGOTTEN FACTOR;Arquivos de Gastroenterologia;2022-06

4. IL28B遺伝子多型の発見から臨床応用②臨床応用;Kanzo;2021-04-01

5. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?;Journal of Clinical and Experimental Hepatology;2020-01